
Biotech boom may continue through earnings season
Don’t look now, but biotech stocks could be getting a jolt as a number of earnings reports are expected this week.
Don’t look now, but biotech stocks could be getting a jolt as a number of earnings reports are expected this week.
When it comes to the economy and the stock market, there are a multitude of factors that can affect growth.
The biotech sector has continued to thrive over the last year, starkly contrasting the disappointments that many investors have experienced in other areas of the market.
While the broader market has mostly been a series of zigs-and-zags this year, the runup in biotech stocks has continued unabated.
You know things are going well in a sector when both growth and value investors are finding ways to get in.
More than three months ago, Federal Reserve Chairman Janet Yellen caught analysts and investors attention when she expressed during congressional testimony dismay at valuations of smaller firms in ...
In one sense, the rally in biotech stocks has been a microcosm of the broader market – any dips or pullbacks have largely proven to be opportunities to buy equities at lower prices before another...
There’s no rest for the wicked – or for those investing in biotech stocks, it seems.
Expectations that 2013 will be a huge year for big-ticket mergers in the biotech sector crystallized a bit more this week with news that laboratory-equipment maker Thermo Fisher Scientific (TMO) wa...